Gender-related features of risk factors for, and age- and gender-related differences in the severity and genesis of chronic heart failure


Cite item

Full Text

Abstract

Aim. To analyze the gender-related features of the prevalence of chronic heart failure (CHF) in Azerbaijan and to estimate the detection rate and risk factors of this condition in inpatients on the basis of a retrospective follow-up study. Materials and methods. A total of 1824 case histories of CHF patients admitted with a CHF diagnosis to the Azerbaijan Research Institute of Cardiology in 2013 were analyzed. Results. The prevalence of CHF is 51.4% among the patients admitted to the Azerbaijan Research Institute of Cardiology. The major etiological factors of CHF are ischemic heart disease (IHD) and hypertension in 79.9% of the. There are gender-related differences in the pattern of cardiovascular diseases in the patients with CHF: IHD (prior myocardial infarction) and hypertension are more common in men and women, respectively. The incidence of CHF was 56.8% among the men; it was registered in them 1.3-fold more often than in the women; 41% of the patients with CHF were older than 60 years. CHF with a left ventricular ejection fraction of <45% was diagnosed in 84% of the patients. Among the patients with CHF and preserved left ventricular ejection fraction, the number of women rose up to 22%, which was twice higher than that for the men. Conclusion. Substantial differences were found in the etiology of CHF in men and women, as well as in patients of different ages.

References

  1. Фомин И.В., Мареев В.Ю., Щербинина Е.В. Показатели распространенности сердечной недостаточности и эффективности ее терапии в зависимости от тяжести заболевания. Сердеч недостат 2002; 3 (2): 69—70.
  2. Фомин И.В. Проблемы исследования распространенности хронической сердечной недостаточности в репрезентативных выборках; Дизайн исследования «ЭПОХА». Хроническая сердечная недостаточность. Гл. 1. Эпидемиология хронической сердечной недостаточности в Европейской части Российской Федерации. М: ГЭОТАР-Медиа 2010: 7—18.
  3. Gillum R.F. Epidemiology of heart failure in the United States. Am Heart J l993; 126: 1042—1047.
  4. McMurray J.J., Stewart S. Epidemiology, aetiology, and prognosis of heart failure. Heart 2000; 83: 596—602.
  5. Mosterd A., Hoes A.W. Clinical epidemiology of heart failure. Heart 2007; 93: 1137—1146.
  6. Cowie M.R., Mosterd A., Wood D.A., Deckers J.W., Poole-Wilson P.A., Sutton G.C., Grobbee D.E. The epidemiology of heart failure. Eur Heart J l 997; 18: 208—225.
  7. Ho K.K., Pinsky J.L., Kannel W.B., Levy D. The epidemiology of heart failure: The Framingham Study. J Am Col Cardiol 1993; 22: 6A—13A.
  8. Bleumink G.S., Knetsch A.M., Sturkenboom M.C., Straus S.M., Hofman A., Deckers J.W., Witteman J.C., Stricker B.H. Quantifying the heart failure epidemic: prevalence, incidence rate, lifetime risk and prognosis of heart failure: The Rotterdam Study. Eur Heart J 2004; 25: 1614—1619.
  9. Tendera M.J. The epidemiology of heart failure. Renin Angiotensin Aldosterone Syst 2004; 5 (Suppl. 1): 2—6.
  10. Garrison G.E., McDonough J.R., Hames C.G., Stulb S.C. Prevalence of chronic congestive heart failure in the population of Evans Country, Georgia. Am J Epidemiol 1966; 83: 338—344.
  11. Ceia F., Fonseca C., Mota T., Morais H., Matias F., de Sousa A., Oliveira A.; EPICA Investigators. Prevalence of chronic heart failure in Southwestern Europe: the EPICA study. Eur J Heart Fail 2002; 4: 531—539.
  12. Власов В.В. Эпидемиология: учебное пособие. М: ГЭОТАР-Медиа 2006; 464.
  13. Диагностика и лечение артериальной гипертензии. Рекомендации Российского медицинского общества по артериальной гипертонии и Всероссийского научного общества кардиологов (третий пересмотр). Кардиоваск тер и проф 2008; 6 (Прил. 2): 1—32.
  14. Declaration of Helsinki. World Medical Association. URL: http://www.wma.net/e/ethicsunit/helsinki.htm
  15. Good Epidemiological Practice (GEP): proper conduct in epidemiological research. European Epidemiological Federation. URL: http://dundee.ac.ulc/iea/Good Pract.htm.
  16. Сергиенко В.И., Бондарева И.Б. Математическая статистика в клинических исследованиях. Практическое руководство. М: ГЭОТАР-Медиа 2006; 304.
  17. Ahmad O.B., Boschi-Pinto C., Lopez A.D. Age standartization of rates: a new WHO standart. Geneva: World Health Organization 2001. URL: http://www.who.int/healthinfor/paper31.
  18. Hudson M., Rahme E., Behlouli H., Sheppard R., Pilote L. Sex differences in the effectiveness of angiotensin receptor blockers and angiotensin converting enzyme inhibitors in patients with congestive heart failure — a population study. Eur J Heart Fail 2007; 9 (6—7): 602—609.
  19. Беленков Ю.Н., Мареев В.Ю. Агеев Ф.Т., Даниелян М.О. Первые результаты национального эпидемиологического исследования — Эпидемиологическое обследование больных ХСН в реальной практике (по обращаемости) ЭПОХА-О-ХСН. От имени рабочей группы «Общества специалистов по сердечной недостаточности». Сердеч недостат 2003; 3: 116.
  20. Фомин И.В., Беленков Ю.Н., Мареев В.Ю., Агеев Ф.Т. Распространенность хронической сердечной недостаточности в Европейской части Российской Федерации данные ЭПОХА-ХСН. Сердеч недостат 2006; 7 (3): 112—114.
  21. Александрова Е.Б. Хроническая сердечная недостаточность у больных гипертонической болезнью и ишемической болезнью сердца: возрастные и гендерные аспекты. Кардиология 2013; 7: 40—44.
  22. Tribouilloy C., Rusinaru D., Mahjoub H., Soulière V., Lévy F., Peltier M., Slama M., Massy Z. Prognosis of heart failure with preserved ejection fraction: a 5 year prospective population-based study. Eur Heart J 2008; 29: 339—347.
  23. Paulus W.J., Tschope C., Sanderson J.E., Rusconi C., Flachskampf F.A., Rademakers F.E., Marino P., Smiseth O.A., De Keulenaer G., Leite-Moreira A.F., Borbély A., Edes I., Handoko M.L., Heymans S., Pezzali N., Pieske B., Dickstein K., Fraser A.G., Brutsaert D.L. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failureand Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007; 28 (20): 2539—2550.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2015 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies